Alexandre LeBeaut

Alexandre P.
LeBeaut is currently the Chief Executive Officer at the Institute For Advanced Clinical Trials For Children.
He is also the Chairman at Ipsen Bioscience, Inc., Versameb AG, and ImmunoRx Pharma, Inc. In addition, he serves as an Independent Director at Calypso Biotech SA, Director at Ipsen (Beijing) Pharmaceutical Science & Technology Dev, Independent Director at Calypso Biotech BV, and Director at Object Pharma, Inc. Dr. LeBeaut is a Member of the American College of Gastroenterology, the Association of Clinical Research Professionals, the American Academy of Pharmaceutical Physicians, and the American Gastroenterological Association.
Formerly, Dr. LeBeaut held positions as an Independent Director at Vifor Pharma AG, Managing Director at Ipsen Pharma SAS, Independent Director at OSE Immunotherapeutics SA, Chief Scientific Officer & Senior Vice President at Aptalis Pharma Canada ULC, Chief Scientific Officer at Ipsen SA, Chief Medical Officer at bluebird bio, Inc., Vice President-Cardiovascular & Medical Affairs at Novartis Pharmaceuticals Corp., Project Leader at Schering-Plough Research Institute, and Principal at Sanofi-Aventis Canada, Inc.Dr. LeBeaut obtained a doctorate degree from Université Paris Diderot-Paris 7.